Evidence map›Paper›PMID 36538894›Full record

ArticleDevelopmental cell2022

ΔNp63/p73 drive metastatic colonization by controlling a regenerative epithelial stem cell program in quasi-mesenchymal cancer stem cells.

Arthur W Lambert, Christopher Fiore, Yogesh Chutake, Elisha R Verhaar, Patrick C Strasser, Mei Wei Chen, Daneyal Farouq, Sunny Das, Xin Li, Elinor Ng Eaton and 13 more

Open access · greenAbstract read
In one paragraph

Article in Developmental cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Ether lipids influence cancer cell fate by modulating iron uptake.bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. EMT and cancer: what clinicians should know.Nature reviews. Clinical oncology · 2025
    Review
  8. Article
  9. Inflammation awakens dormant cancer cells by modulating the epithelial-mesenchymal phenotypic state.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Integrins in cancer stem cells.Frontiers in cell and developmental biology · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 2 countries.

Arthur W LambertWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Christopher FioreSyros Pharmaceuticals, Cambridge, MA 02140, USA.
Yogesh ChutakeSyros Pharmaceuticals, Cambridge, MA 02140, USA.
Elisha R VerhaarWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Patrick C StrasserWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Mei Wei ChenSyros Pharmaceuticals, Cambridge, MA 02140, USA.
Daneyal FarouqSyros Pharmaceuticals, Cambridge, MA 02140, USA.
Sunny DasWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Xin LiWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Elinor Ng EatonWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Yun ZhangWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Joana Liu DonaherWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Ian EngstromWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Ferenc ReinhardtWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Bingbing YuanWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Sumeet GuptaWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Bruce WollisonSyros Pharmaceuticals, Cambridge, MA 02140, USA.
Matthew EatonSyros Pharmaceuticals, Cambridge, MA 02140, USA.
Brian BierieWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
John CarulliSyros Pharmaceuticals, Cambridge, MA 02140, USA.
Eric R OlsonSyros Pharmaceuticals, Cambridge, MA 02140, USA.
Matthew G GuentherSyros Pharmaceuticals, Cambridge, MA 02140, USA.
Robert A WeinbergWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA; MIT Ludwig Center for Molecular Oncology, Cambridge, MA 02139, USA. Electronic address: weinberg@wi.mit.edu.
Whitehead Institute for Biomedical Research · USChinese Academy of Medical Sciences & Peking Union Medical College · CNMolecular Oncology (United States) · US

Funding

Induced Differentiation to Deplete CSCs from Breast CancerR01CA078461 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI WEINBERG, ROBERT A · 1999 to 2017
$8.5M
Epi-genetic Programs in Cancer ProgressionR35CA220487 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI WEINBERG, ROBERT A · 2017 to 2023
$7.3M
NCI NIH HHS R01 CA078461NCI NIH HHS R35 CA220487
6 · The paper itself

Abstract

Cancer stem cells (CSCs) may serve as the cellular seeds of tumor recurrence and metastasis, and they can be generated via epithelial-mesenchymal transitions (EMTs). Isolating pure populations of CSCs is difficult because EMT programs generate multiple alternative cell states, and phenotypic plasticity permits frequent interconversions between these states. Here, we used cell-surface expression of integrin β4 (ITGB4) to isolate highly enriched populations of human breast CSCs, and we identified the gene regulatory network operating in ITGB4

Indexed as

Mesenchymal Stem CellsNeoplasmsCell Line, TumorEpithelial-Mesenchymal TransitionHumansNeoplastic Stem CellsSignal Transductionbreast cancercancer stem cellsEMTepigeneticsmetastasis

Identifiers

PMID36538894
PMCPMC10002472
OpenAlexW4312095302

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.